A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/4418 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2350420
Described are methods for treating, preventing, or reducing the risk of the onset of Alzheimer's disease by administering a therapeutically effective amount of an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase ("HMG CoA reductase inhibitor") to a patient who is at risk for a coronary or cerebrovascular event or at risk for Alzheimer's disease.
La présente invention concerne des méthodes de traitement, de prévention ou de réduction du risque d'apparition de la maladie d'Alzheimer, consistant à administrer à un patient susceptible de subir un accident coronaire ou cérébro-vasculaire ou de développer la maladie d'Alzheimer, une dose efficace sur le plan thérapeutique d'un inhibiteur de 3-hydroxy-3-méthylglutaryl-coenzymeA réductase ("HMG-CoA reductase inhibitor").
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Nymox Corporation
LandOfFree
Methods for treating, preventing, and reducing the risk of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating, preventing, and reducing the risk of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating, preventing, and reducing the risk of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1630389